Glucopyranosyl derivatives and their uses
AssigneeSunshine Lake Pharma Co., Ltd.
InventorsZheng Gu, Wuyong Wu, Panpan Kang, Weihua Wang, Jianyu Liu, Xinshan Deng
Life of this patent
Estimating the term…
Abstract
At present relates to a glucopyranosyl derivative and application thereof. In particular, relates to a glucopyranosyl derivative as a sodium-dependent glucose transporters1 (SGLT1) inhibitor, and a pharmaceutically acceptable salt or a stereoisomer thereof, and further relates to a pharmaceutical composition containing the derivative. Further relating to uses of the compound and pharmaceutical composition thereof in the preparation of drugs for the treatment of diabetes and diabetes-related diseases.
Claims15
A compound having Formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a solvate, a pharmaceutically acceptable salt, a dimer, or a trimer thereof,
- wherein,
- Y is —(CH2)q—, —O—, —NH—, —S—, —S (═O)— or —S (═O)2—;
- q is 0, 1, 2 or 3;
- L is C1-6 alkylene or C1-6 alkenylene, wherein the L is unsubstituted or substituted with 1, 2 or 3 Ry;
- R1 is H, deuterium, F, Cl, Br, I, —OH, —CN, —NO2, —NH2, —SH, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C1-6 haloalkyl, C1-6 haloalkoxy, C1-6 alkylamino, C1-6 alkylthio, cyano C1-6 alkyl, amino C1-6 alkyl, hydroxy C1-6 alkyl or C3-6 cycloalkyl;
- each of R5 and R6 is independently H, deuterium, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C3-6 cycloalkyl, 5-6 membered heterocyclyl, C6-10 aryl or 5-6 membered heteroaryl;
- or R5, R6 together with the nitrogen atom they are attached to, form a 5-6 membered heterocyclic ring or a 5-6 membered heteroaromatic ring;
- R4 is F, Cl, Br, I, OH, CN, NO2, NH2, —SH, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C1-6 haloalkyl, C1-6 haloalkoxy, C1-6 alkylthio, C1-6 alkylamino, hydroxy C1-6 alkyl, cyano C1-6 alkyl, amino C1-6 alkyl, C3-6 cycloalkyl, 5-6 membered heterocyclyl, C6-10 aryl or 5-6 membered heteroaryl, wherein each of the C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C1-6 haloalkyl, C1-6 haloalkoxy, C1-6 alkylthio, C1-6 alkylamino, hydroxy C1-6 alkyl, cyano C1-6 alkyl, amino C1-6 alkyl, C3-6 cycloalkyl, 5-6 membered heterocyclyl, C6-10 aryl or 5-6 membered heteroaryl is independently unsubstituted or substituted with 1, 2 or 3 Rx;
- each of R2 and R3 is independently H, deuterium, F, Cl, Br, I, OH, CN, NO2, NH2, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C1-6 haloalkyl, C1-6 haloalkoxy, C1-6 alkylamino, C1-6 alkylthio, hydroxy C1-6 alkyl, cyano C1-6 alkyl, or amino C1-6 alkyl;
- or R2, R3 together with
- they are attached to, form
- wherein the bond to the R2 group is identified by *, and the bond to the R3 group is identified by **;
- each of R7 and R8 is independently H, deuterium, F, Cl, Br, I, OH, CN, NO2, NH2, —SH, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C1-6 haloalkyl, C1-6 haloalkoxy, C3-8 cycloalkyl, 3-8 membered heterocyclyl, C6-10 aryl or 5-8 membered heteroaryl, wherein each of the C1-6 alkyl, C1-6 alkoxy, C1-6 alkylamino, C1-6 haloalkyl, C1-6 haloalkoxy, C3-8 cycloalkyl, 3-8 membered heterocyclyl, C6-10 aryl or 5-8 membered heteroaryl is independently unsubstituted or substituted with 1, 2 or 3 Rw;
- or R7, R8 and the carbon atom to which they are attached form a C3-8 carbocyclic ring or a 3-8 membered heterocyclic ring, wherein each of the C3-8 carbocyclic ring and 3-8 membered heterocyclic ring is independently unsubstituted or substituted with 1, 2 or 3 Rw;
- each Rx, Ry, and Rw is independently deuterium, F, Cl, Br, I, CN, NO2, OH, NH2, —SH, ═O, —C (═O) OH, —C(═O)NH2, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 alkylamino or C1-6 haloalkoxy;
- wherein, the compound does not include
Dependencies are inferred from the claim text.